Clinical Trial Update: To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of pegozafermin in subjects with severe hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Pegozafermin (pegozafermin)

Snippet

Sponsor: 89bio, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: COMPLETED